Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5693 record(s)

Req # A-2023-001561

Adverse Drug Reaction (ADR). Report number: E2B_06694691.

Organization: Health Canada

16 page(s)
June 2024

Req # A-2023-001576

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-112026-78.

Organization: Health Canada

19 page(s)
June 2024

Req # A-2023-001582

Adverse Drug Reactions (ADRs) for Leuprorelin. Report numbers: E2B_06058779, E2B_06137873, E2B_06149226, E2B_06153462, E2B_06155423, E2B_06242847, E2B_06249825, E2B_06257614, E2B_06260684.

Organization: Health Canada

69 page(s)
June 2024

Req # A-2023-001584

Adverse Drug Reaction (ADR) for Bosentan. Report number: E2B_06842555.

Organization: Health Canada

9 page(s)
June 2024

Req # A-2024-000026

Adverse Drug Reaction (ADR). Report number: E2B_06617133.

Organization: Health Canada

12 page(s)
June 2024

Req # A-2024-000058

Adverse Drug Reactions (ADRs). Report numbers: 1075287, E2B_06905487.

Organization: Health Canada

25 page(s)
June 2024

Req # A-2024-000094

Adverse Drug Reactions (ADRs) for Haegarda. Report numbers: E2B_06634366, E2B_06362541.

Organization: Health Canada

27 page(s)
June 2024

Req # A-2024-000095

Adverse Drug Reactions (ADRs) for Hizentra. Report numbers: E2B_06322702, E2B_06568254.

Organization: Health Canada

31 page(s)
June 2024

Req # A-2024-000113

Adverse Drug Reactions (ADRs). Report numbers: E2B_06927837, E2B_06953520.

Organization: Health Canada

91 page(s)
June 2024

Req # A-2024-000114

Adverse Drug Reactions (ADRs). Report numbers: E2B_06935609, E2B_06954605.

Organization: Health Canada

219 page(s)
June 2024
Date modified: